Cronos (CRON) Long-Term Investments (2016 - 2026)
Cronos (CRON) posted quarterly Long-Term Investments of $5.2 million for Q1 2026, up 88.71% year-over-year from $2.8 million in Q1 2025, and down 32.16% quarter-over-quarter from $7.7 million in Q4 2025.
Cronos (CRON) Long-Term Investments (2016 - 2026) Analysis & Trends
Cronos' Long-Term Investments history runs 11 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 88.71% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 88.71% YoY), while the FY2025 annual figure was $7.7 million, up 172.45% from the prior year.
- Long-Term Investments for Q1 2026 stood at $5.2 million, down from $7.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $111.8 million in Q1 2022, with the low at $2.3 million in Q2 2025.
- The 5-year median for Long-Term Investments is $19.8 million (2024), against an average of $39.5 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Investments soared 481.45% in 2022, then plunged 95.34% in 2024.
- Cronos' Long-Term Investments stood at $71.0 million in 2022, then sank by 50.35% to $35.3 million in 2023, then tumbled by 92.02% to $2.8 million in 2024, then surged by 172.45% to $7.7 million in 2025, then slumped by 32.16% to $5.2 million in 2026.
- Business Quant data shows CRON's Long-Term Investments at $5.2 million in Q1 2026, $7.7 million in Q4 2025, and $11.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 7.66 Mn |
| Sep 30, 2025 | 11.44 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 19.76 Mn |
| Dec 31, 2023 | 35.25 Mn |
| Sep 30, 2023 | 62.14 Mn |
| Jun 30, 2023 | 67.93 Mn |
| Mar 31, 2023 | 62.83 Mn |
| Dec 31, 2022 | 70.99 Mn |
| Sep 30, 2022 | 94.56 Mn |
| Jun 30, 2022 | 108.67 Mn |
| Mar 31, 2022 | 111.76 Mn |
| Dec 31, 2021 | 118.39 Mn |
| Sep 30, 2021 | 19.09 Mn |